Stansberry Research

The Investing Tool You’re Probably Ignoring

Want to understand a company’s real incentives? Start with the proxy statement.

Watch the full video on our YouTube channel.

The Investing Tool You’re Probably Ignoring

The #1 Thing To Watch In An SEC Filing

The CRAZY Things Hidden in SEC Filings

Would You Quit A $600k Part-Time Job?

This One Filing Can Tell You When to Buy or Sell Stocks

🔔 Gain an instant edge over Wall Street: https://stansberrydigest.com/

Most investors ignore this document.

They throw it away… delete the email… or never even open it.

But inside this “boring” SEC filing could ...be the difference between buying the right stock… or holding the wrong one.

So the real question is:

What are companies quietly telling you — that they’re not saying out loud?

In this week’s Stansberry Investor Hour, Dan welcomes back Michelle Leder, founder of Footnoted.com and one of the leading experts in SEC filings. Michelle explains why proxy statements — often dismissed as tedious and irrelevant — may actually be one of the most powerful tools individual investors have.

She breaks down how these filings reveal what executives are really paid, how insiders are incentivized, and where potential red flags may be hiding in plain sight. From unusual compensation structures to related-party transactions and shareholder proposals, Michelle shows how to uncover insights that most investors completely miss.

The conversation also explores why proxy season (right now) is one of the most important times of the year for investors, how to quickly navigate 80+ page filings without getting overwhelmed, and why “there are no accidents” in SEC disclosures — everything is there for a reason.

Finally, Michelle shares real examples of how reading SEC filings has helped her spot opportunities, avoid risks, and even identify potential market-moving events before they happen.

Welcome to the hidden side of investing.

CAN’T WATCH THE FULL EPISODE? START HERE:

0:00 – The “Sexiest” SEC Filing Explained
2:00 – Why Most Investors Ignore Proxy Statements
5:00 – Executive Compensation: What to Look For
10:00 – The Hidden Meaning Behind “All Other Compensation”
16:30 – Director Pay & Incentives (Red Flags to Watch)
20:30 – Related-Party Transactions (What Companies Don’t Highlight)
24:45 – Shareholder Proposals & Political Influence
29:00 – Who Really Owns the Company? (Institutional Holders)
35:00 – Why SEC Filings Reveal More Than Earnings Calls
41:00 – Real Example: Spotting Trouble in a Stock
48:00 – “There Are No Accidents” in SEC Filings
51:40 – Final Takeaway: What Every Investor Should Do[+] Show More

AI and the "493"

What's Next for GLP-1 Drugs?

No Rate Cuts In 2026?

The Mag 7 Trade Is Breaking… Here’s What Comes Next

🔔 Gain an instant edge over Wall Street: https://stansberrydigest.com/

In this week’s Stansberry Investor Hour, Dan welcomes macro analyst David Cervantes back to the show. David begins by revisiting one of ...his earliest big calls — the economic impact of GLP-1 weight-loss drugs — and explains how these treatments have moved from niche medical use to a mass-adoption trend with real implications for industries, markets, and long-term growth. He discusses how companies tied to the GLP-1 boom have dramatically outperformed the broader market and why the ripple effects could continue.

Next, David dives into one of the biggest shifts happening in markets today: the potential rotation away from the “Mag 7” tech trade and toward a broader set of sectors. He explains how massive AI capital spending, changing cash-flow expectations, and improving profit margins in global and industrial businesses are reshaping investor preferences. David argues that leadership is beginning to expand beyond mega-cap technology, with equal-weighted indexes, energy, utilities, and industrial companies showing increasing strength.

The conversation then turns to risks building beneath the surface of the financial system — particularly in private credit markets. David walks through why stress in lower-quality debt could be an early warning signal for the broader cycle and explains how late-cycle dynamics, geopolitical uncertainty, and shifting interest-rate expectations are influencing asset allocation decisions. He also shares his view that inflation pressures tied to inventory restocking and a tighter labor market may limit the Federal Reserve’s ability to cut rates as much as investors expect.

Finally, David discusses structural changes in the investment landscape, including why small-cap stocks may no longer offer the same long-term advantages they once did and how private equity has reshaped public markets. He concludes by outlining where he sees opportunities today — from defense and energy to logistics and industrial suppliers — and explains how productivity gains from AI adoption could gradually lift margins across the broader economy.

0:00 GLP-1 drugs and their impact on markets and industries
12:40 Rotation beyond the Mag 7; sector leadership shifts
19:00 Private credit stress and late-cycle warning signs
28:30 The U.S. dollar, global capital flows, and market positioning
35:30 Why small caps may be structurally disadvantaged
46:30 Restocking trends, inflation risk, and Fed policy outlook
51:40 Trade ideas: defense, energy, logistics, and industrials
01:00:00 Dan’s final thoughts[+] Show More